About FDA

Division of Oncology Products 1 (DOP1)

Director: Amna Ibrahim, M.D. (Acting)
Deputy Director: Geoffrey Kim, M.D. (Acting)
Deputy Director of Safety: Katherine Fedenko 

Safety Regulatory Project Manager (SRPM): Susan Jenney
Chief Project Management Staff: Christy Cottrell
Chief Project Management Staff: Alice Kacuba

Secretary: Dolores Bowen

The Division of Oncology Products 1 (DOP1) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for the following therapeutics areas:

  1. Breast Cancer
  2. Gynecologic Cancers
  3. Genitourinary Cancers
  4. Supportive care (non-hematologic) Products

Mailing Address:

Food and Drug Administration
Center for Drug Evaluation and Research
Division of Oncology Products 1 (DOP1)
5901-B Ammendale Road
Beltsville, MD 20705-1266

Phone:  (301) 796-2330
Fax: (301) 796-9845

Page Last Updated: 10/15/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English